within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC21_Treprostinil;

model Treprostinil_1
  extends Pharmacolibrary.Drugs.ATC.B.B01AC21_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B01AC21_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Treprostinil is a stable, synthetic analog of prostacyclin (PGI2) used primarily for the treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity. It acts as a vasodilator of pulmonary and systemic arterial vascular beds and inhibits platelet aggregation. It is approved for use in several countries and can be administered intravenously, subcutaneously, orally, or by inhalation.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults after oral administration of treprostinil extended-release tablets.</p><h4>References</h4><ol><li><p>Hopper, RK, et al., &amp; Feinstein, JA (2020). Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension. <i>Journal of cardiovascular pharmacology</i> 76(1) 94–100. DOI:<a href=\"https://doi.org/10.1097/FJC.0000000000000842\">10.1097/FJC.0000000000000842</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32398473/\">https://pubmed.ncbi.nlm.nih.gov/32398473</a></p></li><li><p>Jones, A, et al., &amp; Laliberte, K (2014). Pharmacokinetics of 3 times a day dosing of oral treprostinil in healthy volunteers. <i>Journal of cardiovascular pharmacology</i> 63(3) 227–232. DOI:<a href=\"https://doi.org/10.1097/FJC.0000000000000039\">10.1097/FJC.0000000000000039</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24603117/\">https://pubmed.ncbi.nlm.nih.gov/24603117</a></p></li><li><p>White, RJ, et al., &amp; Tapson, VF (2013). Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertension. <i>Journal of cardiovascular pharmacology</i> 61(6) 474–481. DOI:<a href=\"https://doi.org/10.1097/FJC.0b013e31828685da\">10.1097/FJC.0b013e31828685da</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23328389/\">https://pubmed.ncbi.nlm.nih.gov/23328389</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Treprostinil_1;
